ImportRefusal LogoImportRefusal

Dormer Laboratories Inc

⚠️ High Risk

FEI: 3001344828 • Etobicoke, Ontario • CANADA

FEI

FEI Number

3001344828

📍

Location

Etobicoke, Ontario

🇨🇦

Country

CANADA
🏢

Address

91 Kelfield St Unit 5, , Etobicoke, Ontario, Canada

High Risk

FDA Import Risk Assessment

51.6
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

4
Total Refusals
4
Unique Violations
11/12/2024
Latest Refusal
8/9/2002
Earliest Refusal

Score Breakdown

Violation Severity
78.0×40%
Refusal Volume
25.9×30%
Recency
62.3×20%
Frequency
1.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
11/12/2024
64XDY99KERATOLYTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/24/2013
80LDHSYSTEM, DELIVERY, ALLERGEN AND VACCINE
16DIRECTIONS
71NO LICENSE
New Orleans District Office (NOL-DO)
8/14/2003
76EMEPUNCH, BIOPSY, SURGICAL
118NOT LISTED
New Orleans District Office (NOL-DO)
8/9/2002
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Dormer Laboratories Inc's FDA import refusal history?

Dormer Laboratories Inc (FEI: 3001344828) has 4 FDA import refusal record(s) in our database, spanning from 8/9/2002 to 11/12/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dormer Laboratories Inc's FEI number is 3001344828.

What types of violations has Dormer Laboratories Inc received?

Dormer Laboratories Inc has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Dormer Laboratories Inc come from?

All FDA import refusal data for Dormer Laboratories Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.